The North America Blood Glucose Monitoring System market revenue reached approximately $5,650 million in 2025, showing consistent growth from $4,300 million in 2020. The market is on track to surpass $9,250 million by 2035, driven by increasing incidence of diabetes, rising healthcare expenditure, and technological innovation. The spike in adoption rates is particularly pronounced after 2023 due to regulatory approvals and improved insurance coverage. Overall, the decade ahead points to robust CAGR supported by ongoing advancements and expanded use in both hospital and home settings.
Read More - https://bussinessinsights.com/research-report/north-america-blood-glucose-monitoring-system-market
Hospitals remain the primary application segment for blood glucose monitoring systems, reflecting their central role in acute, perioperative, and critical care management of diabetes. Home care follows closely, illustrating the increasing shift to patient self-management in the region. Clinics and diagnostic centers collectively account for a sizeable portion, supported by point-of-care testing and outpatient diabetes programs. The continued rise of ambulatory surgical centers and other non-traditional environments is expanding the application base, but hospitals and home care are set to dominate in 2025.
Request Free Sample- https://bussinessinsights.com/request/healthcare/north-america-blood-glucose-monitoring-system-market
Who are the key players in North America Blood Glucose Monitoring System Market industry?
The top five players are Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Medtronic plc, and Ascensia Diabetes Care. These companies lead the market through technological innovation, robust product portfolios, and extensive distribution networks. Abbott’s FreeStyle Libre and Dexcom’s continuous glucose monitors are especially noteworthy for their market impact and consumer adoption.
What is the North America Blood Glucose Monitoring System Market growth?
The North America Blood Glucose Monitoring System Market is experiencing significant growth, driven by rising diabetes incidence and technology advancement. For instance, Abbott Laboratories reported double-digit growth in FreeStyle Libre sales in 2023, reflecting increased adoption of continuous glucose monitoring systems across the United States and Canada.
Which segment accounted for the largest North America Blood Glucose Monitoring System Market share?
Self-monitoring blood glucose (SMBG) devices hold the largest market share among applications. These devices are widely used for daily glucose tracking, especially among patients with type 1 and type 2 diabetes, due to their affordability, accessibility, and essential role in diabetes self-management across various healthcare settings.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com